JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31

JUPITER NEUROSCIENCES, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$2.75−0.15 (-5.34%)

Close on Oct 19, 2026

Fundamental chart

Pick a measure to chart its full history

$21.80KFY2025

Parsed from the XBRL in Jupiter Neurosciences's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-75 reverse split on Aug 14, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is JUNS.

Gross margin80.6% · median 70.1%

Operating margin-45016.4% · median -8250.5%

Net margin-42206.9% · median -8269.5%

Advertisement
300 × 250